Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ·Healthcare·Biotechnology
$3.39
-1.16%
Mkt Cap $1.15B
Next Earnings
In 9 daysThu, May 7, 2026
EPS Estimate
-$0.19
5 analysts
Revenue Estimate
$77.84M
Last quarter: beat by +18.18% on EPS, +7.44% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$1.15B
P/E
—
Fwd P/E
—
P/S
4.38
Rev TTM
—
EPS TTM
-$1.09